Tilray Brands (TLRY) Net Margin Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Net Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -2,064.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -195.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 376.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -303.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -58.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 306.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 513.31 Mn | 278.68 Mn | 90.52 Mn | 39,263.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 39,263.00 |
| Feb 28, 2026 | 41,493.00 |
| Nov 30, 2025 | 2,042.00 |
| Aug 31, 2025 | 1,804.00 |
| May 31, 2025 | -40,721.00 |
| Feb 28, 2025 | -37,140.00 |
| Nov 30, 2024 | -1,659.00 |
| Aug 31, 2024 | 1,425.00 |
| May 31, 2024 | -9,233.00 |
| Feb 29, 2024 | 76,558.00 |
| Nov 30, 2023 | 3,518.00 |
| Aug 31, 2023 | 1,137.00 |
| May 31, 2023 | 33,888.00 |
| Feb 28, 2023 | -85,587.00 |
| Nov 30, 2022 | -6,275.00 |
| Aug 31, 2022 | -2,235.00 |
| May 31, 2022 | -43,155.00 |
| Feb 28, 2022 | 227.00 |
| Nov 30, 2021 | 7,268.00 |
| Aug 31, 2021 | -209.00 |